Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Immunopathol Pharmacol ; 24(1): 55-62, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21496387

RESUMEN

Previously, K6PC-5, a synthetic derivative of ceramide, was demonstrated to activate sphingosine kinase (SK)-1 in keratinocytes. In this study its potential biological effect in mouse myoblasts was examined. The obtained results show that K6PC-5 promotes myogenic differentiation by enhancing myogenic marker expression, differentiation index and fusion index. Interestingly, its biological action was prevented by pharmacological inhibition of SK or S1P2 receptor, in full agreement with their recognized role in myoblast differentiation. This is the first evidence that pharmacological activation of SK accelerates myogenesis and suggests that this new therapeutic strategy could be possibly employed in skeletal muscle disorders where muscle regeneration is deficient.


Asunto(s)
Amidas/farmacología , Desarrollo de Músculos/efectos de los fármacos , Mioblastos/efectos de los fármacos , Fosfotransferasas (Aceptor de Grupo Alcohol)/fisiología , Animales , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Activación Enzimática/efectos de los fármacos , Ratones , Mioblastos/citología , Receptores de Lisoesfingolípidos/fisiología
2.
Cell Mol Life Sci ; 66(10): 1741-54, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19337690

RESUMEN

Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid which regulates multiple biological parameters in a number of cell types, including stem cells. Here we report, for the first time, that S1P dose-dependently stimulates differentiation of adipose tissue-derived mesenchymal stem cells (ASMC) towards smooth muscle cells. Indeed, S1P not only induced the expression of smooth muscle cell-specific proteins such as alpha-smooth muscle actin (alpha SMA) and transgelin, but also profoundly affected ASMC morphology by enhancing cytoskeletal F-actin assembly, which incorporated alpha SMA. More importantly, S1P challenge was responsible for the functional appearance of Ca(2+) currents, characteristic of differentiated excitable cells such as smooth muscle cells. By employing various agonists and antagonists to inhibit S1P receptor subtypes, S1P(2) turned out to be critical for the pro-differentiating effect of S1P, while S1P(3) appeared to play a secondary role. This study individuates an important role of S1P in AMSC which can be exploited to favour vascular regeneration.


Asunto(s)
Tejido Adiposo/citología , Diferenciación Celular/efectos de los fármacos , Lisofosfolípidos/farmacología , Células Madre Mesenquimatosas/citología , Miocitos del Músculo Liso/citología , Esfingosina/análogos & derivados , Actinina/genética , Actinina/metabolismo , Calcio/metabolismo , Células Cultivadas , Regulación de la Expresión Génica , Humanos , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/metabolismo , Proteínas Musculares/genética , Proteínas Musculares/metabolismo , Potasio/metabolismo , Receptores de Lisoesfingolípidos/agonistas , Receptores de Lisoesfingolípidos/antagonistas & inhibidores , Esfingosina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA